drugset / Trial / NCT00005794

Perifosine in Treating Patients With Advanced Solid Tumors

NCT00005794

Treatment

Summary

RATIONALE: Perifosine may stop the growth of tumor cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of perifosine in treating patients who have advanced solid tumors.

Timeline

Start
2000-02
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Perifosine Small molecule Oral